The ASX has been trading flat at around 7,928 points.

Discretionary has been the best performing sector today, up 1%, followed by Financials, up 0.66%, and Utilities, up 0.5%.

Staples has been the worst performing, down 1%, followed by Materials, down 0.9%, and Industrials, down 0.8%.

Opthea (ASX:OPT) has been the most watched on HotCopper forums today and is in a trading halt. Its COAST Phase 3 trial failed to meet primary endpoint of mean change in best corrected visual acuity from baseline to Week 52. The company is now considering the overall impact of the negative trial result heading into the year.

Also trending: Errawarra Resources (ASX:ERW), which has entered binding agreements to acquire 70% of the historical Elizabeth Hill Silver Project, 70% of the silver rights to the Pinderi Hills Project tenement package, and 70% of the ownership of three tenements  surrounding the silver project.

Rounding out the most discussed has been Memphasys (ASX: MEM), which unveiled the successful unblinding and data analysis of its pivotal clinical trial for the Felix System, confirming its best-in-class performance in sperm selection for Assisted Reproductive Technology.

You’re up to date, see you later for market close.